Jennifer Bealer Biography and Net Worth

Jen is responsible for all day-to-day legal operations at Progyny, including corporate governance, compliance, client contracting, partnerships, labor and employment, intellectual property, data privacy, and regulatory affairs. Prior to joining Progyny, Jen spent 7 years at Ropes & Gray’s nationally ranked health practice where she gained extensive expertise in providing health care clients with strategic, regulatory, compliance, and transaction advice. Jen also leads Progyny’s Allies Group, working alongside the company’s Social Justice Committee to create an inclusive environment that advances actionable change in the pursuit of diversity, equity and social justice, and was named by the New York Law Journal to its prestigious 2020 Trailblazers list.

What is Jennifer Bealer's net worth?: The estimated net worth of Jennifer Bealer is at least $3.00 million as of July 23rd, 2021. Ms. Bealer owns 92,718 shares of Progyny stock worth more than $3,004,063 as of April 23rd. This net worth evaluation does not reflect any other assets that Ms. Bealer may own. Learn More about Jennifer Bealer's net worth.
How do I contact Jennifer Bealer?: The corporate mailing address for Ms. Bealer and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Jennifer Bealer's contact information.
Has Jennifer Bealer been buying or selling shares of Progyny?: Jennifer Bealer has not been actively trading shares of Progyny during the last quarter. Most recently, Jennifer Bealer sold 22,125 shares of the business's stock in a transaction on Monday, November 8th. The shares were sold at an average price of $65.79, for a transaction totalling $1,455,603.75. Learn More on Jennifer Bealer's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, insiders at the sold shares 38 times. They sold a total of 3,784,012 shares worth more than $152,303,570.89. The most recent insider tranaction occured on April, 1st when Chairman David J Schlanger sold 1,000 shares worth more than $37,520.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 4/1/2024.

Jennifer Bealer Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2021	Sell	22,125	$65.79	$1,455,603.75
11/5/2021	Sell	10,090	$65.39	$659,785.10
10/25/2021	Sell	2,688	$63.99	$172,005.12
9/24/2021	Sell	21,291	$64.00	$1,362,624.00
7/23/2021	Sell	1,930	$56.40	$108,852.00	92,718
6/23/2021	Sell	1,940	$60.23	$116,846.20	86,988
4/23/2021	Sell	2,401	$51.47	$123,579.47	88,134
3/23/2021	Sell	2,468	$48.54	$119,796.72	85,844
2/23/2021	Sell	2,472	$49.76	$123,006.72	76,550
1/25/2021	Sell	2,310	$49.79	$115,014.90	66,239
12/23/2020	Sell	1,876	$41.19	$77,272.44	66,238
12/21/2020	Sell	289	$38.72	$11,190.08	66,238
11/23/2020	Sell	1,527	$30.50	$46,573.50	66,239
11/20/2020	Sell	280	$30.02	$8,405.60	66,239
8/24/2020	Sell	1,522	$29.97	$45,614.34	55,293
8/20/2020	Sell	281	$31.20	$8,767.20	52,488
8/11/2020	Sell	25,303	$29.98	$758,583.94	51,831

Jennifer Bealer Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $32.40

$32.34

$33.30

50 Day Range

MA: $36.36

$31.88

$41.38

2 Week Range

Now: $32.40

$29.44

$44.95

Volume

625,184 shs

Average Volume

786,847 shs

Market Capitalization

$3.11 billion

P/E Ratio

52.26

Dividend Yield

N/A

Beta

1.48

Exposed: 10 CENT Crypto to Explode April 20th?

From True Market Insiders | Ad

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024